Clinical Trials Logo

Filter by:
NCT ID: NCT00744874 Completed - Clinical trials for Paroxysmal Atrial Fibrillation

Ablation of the Pulmonary Veins for Paroxysmal Afib

MAP-PAF
Start date: October 2007
Phase: Phase 4
Study type: Interventional

The purpose of this trial was to investigate and confirm the safety, efficacy, and efficiency of the Ablation Frontiers® Cardiac Ablation System when used in the treatment of paroxysmal atrial fibrillation. (PAF)

NCT ID: NCT00744835 Completed - Atrial Fibrillation Clinical Trials

Atrial Fibrillation Ablation Pilot Study

Start date: August 2006
Phase: Phase 1
Study type: Interventional

This is a prospective, non-randomized, multicenter, multi-country pilot study to evaluate the safety and effectiveness of the Ablation Frontiers Cardiac Ablation System for the ablative treatment of symptomatic permanent atrial fibrillation.

NCT ID: NCT00744263 Completed - Clinical trials for Pneumococcal Infections

Study Evaluating the Effiacy of a 13-Valent Pneumococcal Conjugate Vaccine (13vPnC) in Adults

CAPITA
Start date: September 2008
Phase: Phase 4
Study type: Interventional

The purpose of this study is to assess the efficacy of 13-valent pneumococcal conjugate vaccine in the prevention of the first episode of vaccine-type pneumococcal community-acquired pneumonia in adults.

NCT ID: NCT00744224 Completed - Clinical trials for Glucocorticoid-induced Glucometabolic Abnormalities

PREDnisolone-induced Beta-cell Dysfunction Prevented by EXenatide

PREDEX
Start date: February 2009
Phase: N/A
Study type: Interventional

The purpose of this study is to explore whether the GLP-1 receptor agonist exenatide, may prevent glucocorticoid-induced glucometabolic abnormalities and beta-cell dysfunction in healthy subjects.

NCT ID: NCT00744094 Completed - Aging Clinical Trials

Resistance Training in Elderly

Start date: January 2007
Phase: Phase 1/Phase 2
Study type: Interventional

In the present study the investigators aim to determine whether protein supplementation can augment the response to a 12 week resistance training program in healthy elderly men.

NCT ID: NCT00743483 Completed - Cystic Fibrosis Clinical Trials

Efficacy of Bucelipase Alfa (BSSL) in Patients With Cystic Fibrosis and Pancreatic Insufficiency

Start date: August 2008
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the efficacy in patients with cystic fibrosis and pancreatic insufficiency following treatment with BSSL

NCT ID: NCT00743262 Completed - Total Laryngectomy Clinical Trials

Short-term Clinical Feasibility of the New Provox Vega 22.5 Voice Prosthesis

Start date: April 2008
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of this study is to investigate the performance of a new voice prosthesis in comparison with the Provox2 and the Provox ActiValve voice prosthesis in 15 laryngectomized patients. Factors taken into account are clinician and patient satisfaction with the insertion system, patient satisfaction with voice, speech, performance, and maintenance. Voice and speech will also be evaluated for the different prostheses by means of perceptual evaluations and acoustic analysis.

NCT ID: NCT00742768 Completed - Healthy Clinical Trials

Comparison of Absorption of Vitamin K2

Start date: June 2008
Phase: N/A
Study type: Interventional

From previous studies it appeared that menaquinone-7 (MK-7) is the most effective form of vitamin K. The Japanese soya product natto is one of the richest food sources of MK-7. However, the taste of natto is not appreciated by the western society. For this reason the active biological compound is produced as a capsule. Different techniques of encapsulation the vitamin can lead to different absorption profiles with intake. Therefore it is important to study influence of type of encapsulation technique on absorption of menaquinone-7. This study is undertaken to compare absorption of menaquinones between two different encapsulation techniques. Absorption profiles of menaquinone-4 and menaquinone-7 of conventional softgel capsules and newly developed GellpelTM capsules are compared between each other.

NCT ID: NCT00742456 Completed - Obesity Clinical Trials

Microvascular Dilatation After Endogenous Induced Hyperinsulinemia

Start date: January 2009
Phase: N/A
Study type: Interventional

In this study we will examine if the insulin-induced microvascular effects will occur after a physiological stimulus (i.e. a oral glucose tolerance test). With that the physiological importance of the insulin-induced microvascular dilatation can be elucidated. In this study we hypothesize that oral glucose intake and consequently the endogenous induced hyperinsulinemia will lead to insulin-induced microvascular dilatation in healthy normotensive subjects. Furthermore, we suggest that the insulin-mediated microvascular dilatation, resulting from this physiological induced hyperinsulinemia, will be less in hypertensive and obese subjects compared to healthy controls.

NCT ID: NCT00742287 Completed - Smoking Clinical Trials

Cardiovascular Effects of Oligomeric Procyanidins (OPCs) in Smokers

INC001
Start date: February 2009
Phase: N/A
Study type: Interventional

Smoking has been identified as a key risk factor for the development of cardiovascular diseases (CVD). It was found that a persistent increase in levels of oxidative stress and prolonged inflammation play a pivotal role in the pathogenesis of smoking associated CVD. Oligomeric proanthocyanidins (OPCs) are widely known for their anti-oxidant and anti-inflammatory effects, in vitro and in vivo. However, there are hardly any studies available that systematically investigated their acute and long-term effects on vascular function as well as on established biomarkers of oxidative stress and inflammation in an "at risk" population such as smokers. Therefore, the aim of the present study is to investigate the effects of an eight-week supplementation with OPCs on vascular function as well as biomarkers of oxidative stress and inflammation in blood of smokers.